Patient-derived tumor organoid and fibroblast assembloid models for interrogation of the tumor microenvironment in esophageal adenocarcinoma

Benjamin P. Sharpe(University Hospital Southampton NHS Foundation Trust), Tim Underwood(University of Southampton)

Cell Reports Methods

November 27, 2024

10.1016/j.crmeth.2024.100909

Cited by 10

Related Papers

Cancer‐associated fibroblasts predict poor outcome and promote periostin‐dependent invasion in oesophageal adenocarcinoma

|The Journal of Pathology|2014|182

Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts

|Cell Reports Medicine|2022|24

Modulation of the tumour promoting functions of cancer associated fibroblasts by phosphodiesterase type 5 inhibition increases the efficacy of chemotherapy in human preclinical models of esophageal adenocarcinoma

|bioRxiv (Cold Spring Harbor Laboratory)|2020|2

Targetable fibroblast phenotypes and EMT malignant cell states cooperate to promote tumor progression in esophageal adenocarcinoma

|Research Square|2023|2